PRESENTATION
Plain Language Summary 746.pptx (42.93 kB)
DOCUMENT
Graphical Abstract_.pdf (6.41 MB)
VIDEO
Video abstract 746.mp4 (233.17 MB)
1/0
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
media
posted on 2024-05-06, 22:45 authored by Adis journalson behalf of, Amy S. Paller, Elaine C. Siegfried, Eric L. Simpson, Michael J. Cork, Robert Sidbury, Iris H. Chen, Faisal A. Khokhar, Jing Xiao, Ariane Dubost-Brama, Ashish Bansal Article full text
The above features represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2024
